What is Reveleer?
Reveleer operates at the intersection of healthcare innovation and data analytics, providing an AI-powered platform that streamlines the transition toward value-based care. By integrating complex functions such as clinical intelligence, risk adjustment, quality improvement, and member management, the company addresses the core operational inefficiencies that plague modern healthcare organizations. The platform acts as a force multiplier for health plans and providers, enabling them to improve patient outcomes while simultaneously maximizing operational performance. Through its sophisticated software suite, Reveleer empowers stakeholders to navigate the shift from fee-for-service models to value-based arrangements with greater precision and efficiency, solidifying its role as a vital infrastructure provider in the digital health ecosystem.
How much funding has Reveleer raised?
Reveleer has raised a total of $139.9M across 5 funding rounds:
Series A
$2.5M
Other Financing Round
$1.4M
Series C
$6M
Other Financing Round
$65M
Other Financing Round
$65M
Series A (2013): $2.5M with participation from Redhills Ventures and Upfront Ventures
Other Financing Round (2014): $1.4M led by Upfront Ventures and Redhills Ventures
Series C (2020): $6M supported by Boston Millennia Partners and Upfront Ventures
Other Financing Round (2021): $65M featuring Oak HC/FT
Other Financing Round (2024): $65M backed by Hercules Capital
Key Investors in Reveleer
Oak HC/FT
Oak HC/FT is a premier venture growth-equity fund specializing in healthcare information and services, as well as financial services technology, providing strategic counsel and board-level participation to transformative companies.
Hercules Capital
Hercules Capital is a specialty finance firm that provides senior secured venture growth loans to high-growth, innovative companies across the technology and life sciences sectors.
Upfront Ventures
Upfront Ventures is a Los Angeles-based venture capital firm focused on supporting technology-driven businesses in sectors such as SaaS, digital media, and consumer internet.
What's next for Reveleer?
Following this major strategic investment, Reveleer is well-positioned to accelerate its product roadmap and expand its footprint within the enterprise healthcare market. The company's focus will likely shift toward deepening its AI capabilities to further automate clinical workflows and enhance the accuracy of risk adjustment models. As the healthcare industry continues to prioritize cost-efficiency and quality of care, Reveleer's ability to provide actionable insights will be paramount. Future growth strategies will likely involve scaling its sales and marketing efforts to capture a larger share of the health plan market, while potentially exploring new integrations that leverage its existing data assets to drive further value for its clients.
See full Reveleer company page
